|
|
|||
|
||||
OverviewThis volume includes information on recent advances in five important areas: an account of inhibitors of the caspase family of proteolytic enzymes that represent a new class of anti-inflammatory and antiapoptotic agents of potential value in rheumatoid arthritis; and a survey of semi-synthetic and totally synthetic antibiotics and anti-HIV agents and their sites of interaction; the development of inhibitors of the intracellular enzyme acyl-CoA: cholesterol O-acyltransferase (ACAT) for the treatment of hypercholesterolemia; a description of recent progress in growth hormone secretagogues, with the focus on strategies to improve oral bioavailability and duration of action; and information on inhibition of the proteolytic enzyme, hepatitis C protease N-3(NS3), (required for vital replication) as one of the most attractive targets for HCV infections. Full Product DetailsAuthor: F.D. King (SmithKIine Beecham Pharmaceuticals<br>New Frontiers Science Park (North)<br>Third Avenue) , George Lawton , A. W. Oxford , Gwynn P. EllisPublisher: Elsevier Science & Technology Imprint: Elsevier Science Ltd Volume: 42 Dimensions: Width: 15.20cm , Height: 2.30cm , Length: 22.90cm Weight: 0.690kg ISBN: 9780444511430ISBN 10: 0444511431 Pages: 450 Publication Date: 15 April 2004 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: In Print This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||